Sun Pharma seeks EU approval for Organon purchase
By Anna Lauwereys ( October 29, 2026, 09:23 GMT | Insight) -- Indian pharmaceutical company Sun Pharma has asked the EU merger regulator for clearance of its intended acquisition of Organon, a US-based rival company. The European Commission has set a Dec. 12 deadline to decide on the $11.75 billion deal.India-based Sun Pharmaceutical Industries has asked EU regulators to approve its intended purchase of American rival Organon....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.